{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T03:52:44Z","timestamp":1768103564620,"version":"3.49.0"},"reference-count":85,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Sarcoidosis is a granulomatous disorder of unknown etiology characterized by multisystem non-caseating granulomas. Pulmonary hypertension (PH) is a well-known complication of sarcoidosis and is associated with increased morbidity and mortality. The actual epidemiology of sarcoidosis-associated PH (SAPH) remains unknown, and its pathogenesis has not been fully elucidated. SAPH is classified under the miscellaneous category (group 5 of the PH classification). The clinical presentation of SAPH is variable and not always proportional to the severity of sarcoidosis. Appropriate management for SAPH by an experienced physician is important; however, no treatment algorithm for SAPH has been established. Lung transplantation should be considered in refractory cases. Pulmonary arterial hypertension-specific vasodilators targeting the endothelin pathway, nitric oxide pathway, and prostacyclin pathway have improved the clinical functions and hemodynamics in some patients with SAPH.<\/jats:p>","DOI":"10.3390\/medicina61020342","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T11:14:41Z","timestamp":1739531681000},"page":"342","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sarcoidosis-Associated Pulmonary Hypertension"],"prefix":"10.3390","volume":"61","author":[{"given":"Yoshitaka","family":"Morimatsu","sequence":"first","affiliation":[{"name":"Department of Environmental Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2011-8201","authenticated-orcid":false,"given":"Nobuhiro","family":"Tahara","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9298-3504","authenticated-orcid":false,"given":"Masaki","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Respirology, NHO Kyushu Medical Center, Fukuoka 810-0065, Japan"},{"name":"Division of Respirology, Neurology and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munehisa","family":"Bekki","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Tahara","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Eto","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadahiro","family":"Kugai","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Koga","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Maeda-Ogata","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Honda","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiyo","family":"Igata","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2274-4599","authenticated-orcid":false,"given":"Yoshiaki","family":"Zaizen","sequence":"additional","affiliation":[{"name":"Division of Respirology, Neurology and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Tanoue","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kurume University School of Medicine, Kurume 830-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Hoshino","sequence":"additional","affiliation":[{"name":"Division of Respirology, Neurology and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Ishitake","sequence":"additional","affiliation":[{"name":"Department of Environmental Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"ref_1","first-page":"21","article-title":"Right heart impairment in sarcoidosis: Haemodynamic and echocardiographic study","volume":"64","author":"Rizzato","year":"1983","journal-title":"Eur. J. Respir. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.rmed.2018.04.015","article-title":"Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry","volume":"139","author":"Baughman","year":"2018","journal-title":"Respir. Med."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Parikh, K.S., Dahhan, T., Nicholl, L., Ruopp, N., Pomann, G.M., Fortin, T., Tapson, V.F., and Rajagopal, S. (2019). Clinical features and outcomes of patients with sarcoidosis-associated pulmonary hypertension. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-40030-w"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jacc.2009.04.011","article-title":"Diagnosis and assessment of pulmonary arterial hypertension","volume":"54","author":"Badesch","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Update clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Update clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1378\/chest.129.5.1246","article-title":"Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis","volume":"129","author":"Handa","year":"2006","journal-title":"Chest"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"406","DOI":"10.5588\/ijtld.12.0428","article-title":"Sarcoidosis-associated pulmonary hypertension in patients with near-normal lung function","volume":"17","author":"Maimon","year":"2013","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1183\/09031936.05.00083404","article-title":"Pulmonary hypertension in advanced sarcoidosis epidemiology and clinical characteristics","volume":"25","author":"Shorr","year":"2005","journal-title":"Eur. Respir. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1378\/chest.09-2002","article-title":"Survival in sarcoidosis-associated pulmonary hypertension: The importance of hemodynamic evaluation","volume":"138","author":"Baughman","year":"2010","journal-title":"Chest"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1378\/chest.128.3.1483","article-title":"Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension","volume":"128","author":"Sulica","year":"2005","journal-title":"Chest"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00408-012-9442-4","article-title":"Elevated pulmonary arterial systolic pressure in patients with sarcoidosis: Prevalence and risk factors","volume":"191","author":"Rapti","year":"2013","journal-title":"Lung"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1378\/chest.14-2546","article-title":"Prostacycline and oral vasodilator therapy in sarcoidosis-associated pulmonary hypertension: A retrospective case series","volume":"148","author":"Bonham","year":"2015","journal-title":"Chest"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0012-3692(15)37649-2","article-title":"Predicting mortality in patients with sarcoidosis awaiting lung transplantation","volume":"124","author":"Shorr","year":"2003","journal-title":"Chest"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1378\/chest.13-1766","article-title":"Bosentan for sarcoidosis-associated pulmonary hypertension: A double-blind placebo controlled randomized trial","volume":"145","author":"Baughman","year":"2014","journal-title":"Chest"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1440-1843.2010.01872.x","article-title":"Pulmonary hypertension in sarcoidosis: A review","volume":"16","author":"Corte","year":"2011","journal-title":"Respirology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/0046-8177(92)90288-E","article-title":"Pulmonary vascular involvement in sarcoidosis: A report of 40 autopsy cases","volume":"23","author":"Takemura","year":"1992","journal-title":"Human Pathol."},{"key":"ref_20","first-page":"194","article-title":"Sarcoidosis and pulmonary hypertension\u2014A case report","volume":"11","author":"Tayal","year":"2006","journal-title":"Eur. J. Med. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"D100","DOI":"10.1016\/j.jacc.2013.10.033","article-title":"Pulmonary hypertension due to left heart disease","volume":"62","author":"Vachiery","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1152\/ajplung.00031.2013","article-title":"The role of distributed blood flow in the development of pulmonary arterial hypertension: Lessons from preclinical animal models","volume":"305","author":"Dickinson","year":"2013","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.hlc.2016.05.125","article-title":"Pulmonary Hypertension due to Radiofrequency Catheter Ablation (RFCA) for Atrial Fibrillation: The Lungs, the Atrium or the Ventricle?","volume":"25","author":"Verma","year":"2016","journal-title":"Heart Lung Circ."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jacep.2023.11.005","article-title":"Pulsed-Field Ablation Does Not Worsen Baseline Pulmonary Hypertension Following Prior Radiofrequency Ablations","volume":"10","author":"Mohanty","year":"2024","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1378\/chest.128.4.2116","article-title":"Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure","volume":"128","author":"Ferrier","year":"2005","journal-title":"Chest"},{"key":"ref_26","first-page":"61","article-title":"Sleep apnea in sarcoidosis","volume":"14","author":"Turner","year":"1997","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_27","first-page":"146","article-title":"First presentation of sarcoidosis with severe obstructive sleep apnea and epiglottic involvement","volume":"30","author":"Ahmed","year":"2013","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1378\/chest.15-0584","article-title":"Interrelationship between sleep-disordered breathing and sarcoidosis","volume":"148","author":"Lai","year":"2015","journal-title":"Chest"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1183\/09059180.00009111","article-title":"Risk factors for chronic thromboembolic pulmonary hypertension","volume":"21","author":"Kim","year":"2012","journal-title":"Eur. Respir. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S2213-2600(14)70089-X","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"2","author":"Hoeper","year":"2014","journal-title":"Lancet Respir. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"477","DOI":"10.5114\/ceji.2015.56972","article-title":"Venous thromboembolism and sarcoidosis: Co-incidence or coexistence?","volume":"40","author":"Geremek","year":"2015","journal-title":"Cent. Eur. J. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.chest.2016.09.009","article-title":"Association of sarcoidosis with increased risk of VTE: A population-based study, 1976 to 2013","volume":"151","author":"Ungprasert","year":"2017","journal-title":"Chest"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/thx.2010.134429","article-title":"Evidence for association between sarcoidosis and pulmonary embolism from 35-year record linkage study","volume":"66","author":"Crawshaw","year":"2011","journal-title":"Thorax"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1378\/chest.78.6.888","article-title":"Major pulmonary artery stenosis causing pulmonary hypertension in sarcoidosis","volume":"78","author":"Damuth","year":"1980","journal-title":"Chest"},{"key":"ref_35","first-page":"341","article-title":"Sarcoidosis-associated fibrosing mediastinitis with resultant pulmonary hypertension: A case report and review of the literature","volume":"79","author":"Toonkel","year":"2010","journal-title":"Respir. Int. Rev. Thorac. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1440-1746.2003.03335.x","article-title":"Clinical manifestations of sarcoid liver disease","volume":"19","author":"Blich","year":"2004","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_37","first-page":"2278","article-title":"Revisiting Cystic Lung Disease\u2014A Review on Diagnostic Approach in High Resolution Computed Tomography Thorax","volume":"10","author":"Ramachandran","year":"2021","journal-title":"J. Evolution Med. Dental Sci."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Colman, R., Whittingham, H., Tomlinson, G., and Granton, J. (2014). Utility of the physical examination in detecting pulmonary hypertension. A mixed methods study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0108499"},{"key":"ref_39","first-page":"108","article-title":"Pulmonary hypertension in sarcoidosis","volume":"23","author":"Baughman","year":"2006","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1183\/13993003.01319-2015","article-title":"Pulmonary artery diameter to predict pulmonary hypertension in pulmonary sarcoidosis","volume":"47","author":"Huitema","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7734","DOI":"10.1378\/chest.07-0116","article-title":"High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis","volume":"132","author":"Zisman","year":"2007","journal-title":"Chest"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1183\/09031936.00175907","article-title":"Clinical predictors of pulmonary hypertension in sarcoidosis","volume":"32","author":"Bourbonnais","year":"2008","journal-title":"Eur. Respir. J."},{"key":"ref_43","first-page":"317","article-title":"The association between BNP, 6MWD test, DLCO% and pulmonary hypertension in sarcoidosis","volume":"33","author":"Mirsaeidi","year":"2016","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2012.10.009","article-title":"Echocardiography in pulmonary arterial hypertension: From diagnosis to prognosis","volume":"26","author":"Bossone","year":"2013","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_45","first-page":"97","article-title":"Can pulmonary arterial hypertension be predicted by non-invasive approach? Echocardiographic and haemodynamic study","volume":"39","author":"Bertoli","year":"1984","journal-title":"Acta Cardiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.rmed.2008.03.022","article-title":"Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis","volume":"102","author":"Nathan","year":"2008","journal-title":"Respir. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1378\/chest.15-0615","article-title":"Histopathology of explanted lungs from patients with a diagnosis of pulmonary sarcoidosis","volume":"149","author":"Zhang","year":"2016","journal-title":"Chest"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/PAS.0b013e3182785a2d","article-title":"End-stage sarcoid lung disease is distinct from usual interstitial pneumonia","volume":"37","author":"Lauren","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00947964","article-title":"Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography","volume":"21","author":"Brudin","year":"1994","journal-title":"Eur. J. Nucl. Med."},{"key":"ref_50","first-page":"44","article-title":"Volumetric FDG PET analysis of global lung inflammation: New tool for precision medicine in pulmonary sarcoidosis?","volume":"35","author":"Adams","year":"2018","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13550-019-0505-x","article-title":"Quantification of pulmonary disease activity in sarcoidosis measured with 18F-FDG PET\/CT: SUVmax versus total lung glycolysis","volume":"9","author":"Schimmelpennink","year":"2019","journal-title":"EJNMMI Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.rmed.2012.11.011","article-title":"Severity of pulmonary involvement and (18)F-FDG PET activity in sarcoidosis","volume":"107","author":"Mostard","year":"2013","journal-title":"Respir. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s12350-009-9110-0","article-title":"Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis","volume":"16","author":"Langah","year":"2009","journal-title":"J. Nucl. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1007\/s12350-021-02684-w","article-title":"Localization of myocardial FDG uptake for prognostic risk stratification in corticosteroid-na\u00efve cardiac sarcoidosis","volume":"29","author":"Bekki","year":"2022","journal-title":"J. Nucl. Cardiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1378\/chest.113.1.237","article-title":"Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease","volume":"113","author":"Palmer","year":"1998","journal-title":"Chest"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/thx.2005.042838","article-title":"Pulmonary hypertension associated with sarcoidosis: Mechanisms, haemodynamics and prognosis","volume":"61","author":"Nunes","year":"2006","journal-title":"Thorax"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1183\/09031936.93.03040403","article-title":"Effects of corticosteroid treatment on pulmonary haemodymanics in patients with sarcoidosis","volume":"3","author":"Gluskowski","year":"1990","journal-title":"Eur. Respir. J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1700465","DOI":"10.1183\/13993003.00465-2017","article-title":"Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension","volume":"50","author":"Boucly","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1378\/chest.08-1881","article-title":"Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience","volume":"135","author":"Barnett","year":"2009","journal-title":"Chest"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1378\/chest.120.3.866","article-title":"Vasoresponsiveness of sarcoidosis-associated pulmonary hypertension","volume":"120","author":"Person","year":"2001","journal-title":"Chest"},{"key":"ref_61","first-page":"110","article-title":"Inhaled iloprost for sarcoidosis associated pulmonary hypertension","volume":"26","author":"Baughman","year":"2009","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1378\/chest.130.5.1481","article-title":"Sarcoidosis-associated pulmonary hypertension: Outcome with long-term epoprostenol treatment","volume":"130","author":"Fisher","year":"2006","journal-title":"Chest"},{"key":"ref_63","first-page":"139","article-title":"Ambrisentan for sarcoidosis associated pulmonary hypertension","volume":"28","author":"Judson","year":"2011","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_64","first-page":"74","article-title":"Safety of macitentan in sarcoidosis-associated pulmonary hypertension: A case-series","volume":"37","author":"Mathijssen","year":"2020","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.healun.2007.11.576","article-title":"Pulmonary hypertension in end-stage pulmonary sarcoidosis: Therapeutic effect of sildenafil?","volume":"27","author":"Milman","year":"2008","journal-title":"J. Heart Lung Transplant."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1086\/688775","article-title":"Tadarafil therapy for sarcoidosis-associated pulmonary hypertension","volume":"6","author":"Ford","year":"2016","journal-title":"Pulm. Circ."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1183\/09031936.00175511","article-title":"Management of end-stage sarcoidosis: Pulmonary hypertension and lung transplantation","volume":"39","author":"Shlobin","year":"2012","journal-title":"Eur. Respir. J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/pgmj.58.679.282","article-title":"Reversible pulmonary hypertension in sarcoidosis","volume":"58","author":"Davis","year":"1982","journal-title":"Postgrad. Med. J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1378\/chest.97.2.500","article-title":"Successful treatment of sarcoidosis-associated pulmonary hypertension with corticosterids","volume":"97","author":"Rodman","year":"1990","journal-title":"Chest"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/MCP.0000000000000075","article-title":"Advanced pulmonary sarcoidosis","volume":"20","author":"Valeyre","year":"2014","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_71","first-page":"e2023027","article-title":"Pulmonary fibrosis in sarcoidosis","volume":"40","author":"Asif","year":"2023","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1055\/s-0040-1709495","article-title":"Advanced pulmonary sarcoidosis","volume":"41","author":"Gupta","year":"2020","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/MCP.0000000000000301","article-title":"From granuloma to fibrosis: Sarcoidosis associated pulmonary fibrosis","volume":"22","author":"Bonham","year":"2016","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/MCP.0b013e3283642a7a","article-title":"Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: Integrating systematic literature research and expert opinion of sarcoidologists worldwide","volume":"19","author":"Cremers","year":"2013","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_75","first-page":"217","article-title":"Effectiveness and tolerability of methotrexate in pulmonary sarcoidosis: A single center real-world study","volume":"36","author":"Fang","year":"2019","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1378\/chest.12-1728","article-title":"Methotrexate vs azathioprine in second-line therapy of sarcoidosis","volume":"144","author":"Vorselaars","year":"2013","journal-title":"Chest"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"190146","DOI":"10.1183\/16000617.0146-2019","article-title":"Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis","volume":"29","author":"Rahaghi","year":"2020","journal-title":"Eur. Respir. Rev."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1183\/09031936.00224513","article-title":"Rituximab in the treatment of refractory pulmonary sarcoidosis","volume":"43","author":"Sweiss","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2004079","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMoa1503184","article-title":"Selexipag for the treatment of pulmonary arterial hypertension","volume":"373","author":"Sitbon","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"33","author":"Barst","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S2213-2600(15)00544-5","article-title":"BMPR2 mutations and survival in pulmonary arterial hypertension: An individual participant data meta-analysis","volume":"4","author":"Evans","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2004229","DOI":"10.1183\/13993003.04229-2020","article-title":"Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation","volume":"58","author":"Montani","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1801899","DOI":"10.1183\/13993003.01899-2018","article-title":"Genetics and genomics of pulmonary arterial hypertension","volume":"53","author":"Morrell","year":"2019","journal-title":"Eur. Respir. J."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/2\/342\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:34:44Z","timestamp":1760027684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/2\/342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":85,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["medicina61020342"],"URL":"https:\/\/doi.org\/10.3390\/medicina61020342","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]}}}